Caldera Medical Acquires Gynecare TVT Product Line from Johnson & Johnson to Expand Women's Health Portfolio
Caldera Medical
Developer of Women's Health Medical Devices
Johnson & Johnson
Medical Device R&D and Manufacturer
Caldera MedicalAnnouncing its acquisition of Ethicon, a Johnson & Johnson companyGynecare TVTproduct series, and will complete the product transition in the coming months. This strategic milestone continues Caldera Medical's 23-year commitment to providing superior therapies and improving the quality of life for women worldwide.
Executive Evaluation
"This acquisition marks a significant advancement in our mission to transform women's health. By incorporating the TVT product line, we further strengthen our steadfast commitment to providing doctors and their patients with safe and effective solutions. We are deeply honored to carry on the legacy of this iconic product series, expanding its global reach to offer more women access to clinically proven treatment options."
---Bryon Merade CEO of Caldera Medical
In the coming months,Caldera MedicalCaldera Medical will enhance global customer support for TVT products and invest in improving the diagnosis and treatment standards for more women. With the company's technical expertise in pelvic floor health and the successful experience of TVT products, Caldera Medical further solidifies its position as a leading provider of advanced solutions in women's health.
In recent yearsCaldera MedicalContinuously expanding its gynecological product line through acquisitions, thereby providing comprehensive and advanced solutions to gynecological patients worldwide. In 2023, it acquiredtlantic Therapeutics'Non-Invasive Solution for Bladder Leakage---Innovo; In 2024, acquiredLuminelle's Disposable HysteroscopeUVision360. Including this acquisition by Johnson & JohnsonGynecare TVT, not only canAccelerated the business growth of Caldera Medical and consolidated its leading position in the gynecology field.
For SaleGynecare TVTAfter,Johnson & JohnsonFinally, a sigh of relief.Johnson & Johnson was already banned from sale in the United States in 2019Gynecare TVT, still sold outside the U.S., led to Johnson & JohnsonSales BanGynecare TVTThe reason is very simple.Gynecare TVTMany complications may arise after the surgery, such as the sling...Eroding organs such as the bladder, vaginal wall, and urethra, leading to a significant decline in patients' quality of life. As a result, Johnson & Johnson faces endless litigation in the United States, losing most of the lawsuits. Consequently, Johnson & Johnson has already paid hundreds of millions of dollars in compensation.
In 2023,Johnson & JohnsonFor deceptively marketing female pelvic mesh implants, inLost the appeal and was ordered to pay compensation$302 million；
In 2022, Johnson & Johnson agreed to...AUD 300 million (approximately RMB 1.4 billion)Settled the previous two class action lawsuits in Australia;
2019，Johnson & Johnson Loses Case, Philadelphia Jury Awards Susan McFarland $120 Million, Including $100 Million in Punitive Damages.
Caldera MedicalWilling to accept handGynecare TVTJohnson & Johnson must be laughing in their sleep. This hot potato can finally be put down. It's unknown whether Johnson & Johnson received any money from this acquisition.
Gynecare TVT
Gynecare TVTThe product line includes TVT, TVT Exact, TVT-O, and TVT Abbrevo, offering minimally invasive treatment options for female patients with stress urinary incontinence (SUI).
As part of the acquisition agreement, Caldera Medical will retain the original TVT product manufacturing facilities, raw materials, and specialized manufacturing team to ensure a seamless transition for surgeons, patients, and partners. The product series has over 20 years of accumulated clinical data (including up to 20 years of patient follow-up), with its reliable performance and treatment outcomes remaining unchanged.
Caldera Medical
Caldera MedicalAs a pioneering innovator in the field of women's health, it focuses on the research, development, production, and sales of advanced medical devices for treating gynecological conditions such as stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.Caldera MedicalCentered on minimally invasive surgical solutions, steadfastly fulfilling the mission of "Improving the quality of life for women worldwide."
